MedPath
HSA Approval

VARADIN FILM-COATED TABLETS 5MG

SIN17221P

VARADIN FILM-COATED TABLETS 5MG

VARADIN FILM-COATED TABLETS 5MG

April 22, 2025

PHARMAKOE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAKOE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C01EB17

Manufacturer Information

PHARMAKOE PTE. LTD.

GENEPHARM S.A

Active Ingredients

Ivabradine hydrochloride eqv Ivabradine

5 mg

Ivabradine

Documents

Package Inserts

Varadin Tablet PI.pdf

Approved: April 22, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VARADIN FILM-COATED TABLETS 5MG - HSA Approval | MedPath